Search

Author/Creator Inase, Aki

1. An mTORC1/2 kinase inhibitor enhances the cytotoxicity of gemtuzumab ozogamicin by activation of lysosomal function. (November 2018)

Authors:
Maimaitili, Yimamu; Inase, Aki; Miyata, Yoshiharu; Kitao, Akihito; Mizutani, Yu; Kakiuchi, Seiji; Shimono, Yohei; Saito, Yasuyuki; Sonoki, Takashi; Minami, Hironobu; Matsuoka, Hiroshi
Journal:
Leukemia research
Issue:
Volume 74(2018)
Page Start:
68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. GSK3 inhibitor enhances gemtuzumab ozogamicin‐induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance. Issue 1 (12th December 2022)

Authors:
Inase, Aki; Maimaitili, Yimamu; Kimbara, Shiro; Mizutani, Yu; Miyata, Yoshiharu; Ohata, Shinya; Matsumoto, Hisayuki; Kitao, Akihito; Sakai, Rina; Kawaguchi, Koji; Higashime, Ako; Nagao, Shigeki; Kurata, Keiji; Goto, Hideaki; Kawamoto, Shinichiro; Yakushijin, Kimikazu; Minami, Hironobu; Matsuoka, ...
Journal:
EJHaem
Issue:
Volume 4:Issue 1(2023)
Page Start:
153
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search